Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Alix, Portal"'
Autor:
Vincent Mallet, Stanislas Pol, Alix Portal, Jacques Izopet, Christophe Legendre, Bénédicte Deau, Marie-Laure Chaix, Anne-Marie Roque-Afonso, L. Hauser, Anaïs Vallet-Pichard, Anne Mercadier, Rebecca Sberro-Soussan, A. Beyloune
Publikováno v:
Transplantation. 102:1351-1357
Background After observing a case of plasma exchange-mediated hepatitis E virus (HEV) infection in a kidney transplant recipient, we investigated the relationship between plasma exchange and HEV infection after kidney transplantation. Methods A cohor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8d96ed272316e2f47fe31a9f8280583a
https://doi.org/10.1097/tp.0000000000002185
https://doi.org/10.1097/tp.0000000000002185
Autor:
Nabil, Baba-Hamed, Alix, Portal
Publikováno v:
La Revue du praticien. 69(3)
Canal anal carcinoma. Anal carcinomas are rare, but their incidence has increased in recent years. They are induced by the Human papillomas virus (mostly genotype 16). The prevalence is high among HIV-infected men who have sex with men (MSM) and prim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d97218921c1808def5dd0c19f0083db2
https://pubmed.ncbi.nlm.nih.gov/30983261
https://pubmed.ncbi.nlm.nih.gov/30983261
Autor:
Alexia Boukris, D. Soudan, E. Pommaret, S. Sultan, Paul Benfredj, Nicolas Lemarchand, Manuel Aubert, Nadia Fathallah, Alix Portal, Hélène Pillant-Le Moult, Vincent de Parades
Publikováno v:
Sang thrombose vaisseaux. 28:231-235
Les techniques mini-invasives en chirurgie hemorroidaire, apparues durant les deux dernieres decennies, sont en plein essor. En effet, elles representent une alternative interessante a l’hemorroidectomie tripediculaire classique car, en l’absence
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fdf2e0612e7890b17caac7a6d30d680c
https://doi.org/10.1684/stv.2016.0954
https://doi.org/10.1684/stv.2016.0954
Autor:
Johann Dreanic, Alix Portal, Belinda Tchoundjeu, Christophe Locher, Pascal Hammel, Anne Thirot Bidault, Julien Taieb, Claire Arbaud, David Tougeron, Romain Coriat, Laetitia Dahan, Olivier Dubreuil, Lysiane Marthey, Franck Bonnetain, Christelle De La Fouchardiere, Simon Pernot, Thierry Lecomte, Céline Lepère, Jean-Baptiste Bachet
Publikováno v:
British Journal of Cancer
Background: There is currently no standard second-line treatment for metastatic pancreatic adenocarcinoma (MPA), and progression-free survival is consistently
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c7a220a77b32447497756de6034b49f
https://doi.org/10.1038/bjc.2015.328
https://doi.org/10.1038/bjc.2015.328
Autor:
Simon Pernot, Orianne Colussi, Julien Taieb, Philippe Rougier, Bruno Landi, Aziz Zaanan, Alix Portal, Céline Lepère, Benjamin Verrière, Nathalie Siauve
Publikováno v:
Clinics and Research in Hepatology and Gastroenterology. 38:e23-e26
Summary Introduction Folfirinox has shown a benefit in terms of survival and quality of life in first line treatment of metastatic pancreatic cancer. However, efficacy of second line chemotherapy after folfirinox is still limited. Gemcitabine plus Na
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab28c3069dbdfe7465aa684a1673f2a0
https://doi.org/10.1016/j.clinre.2014.01.005
https://doi.org/10.1016/j.clinre.2014.01.005
Publikováno v:
British Journal of Cancer
Reply to the comment on ‘Nab-paclitaxel plus gemcitabine for metastatic pancreatic adenocarcinoma after Folfirinox failure: an AGEO prospective multicentre cohort’
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::914f721c4222ae09135b8fe383912af3
https://pubmed.ncbi.nlm.nih.gov/27124336
https://pubmed.ncbi.nlm.nih.gov/27124336
Autor:
Alix Portal, Jean-Baptiste Bachet, Olivier Dubreuil, Julien Taieb, Johann Dreanic, David Tougeron, Lysiane Marthey, Romain Coriat, Jean-Louis Legoux, Claire Arbaud, Pascal Hammel, Thierry Lecomte, Céline Lepère, Laetitia Dahan, Anne Thirot-Bidault, Philippe Rougier, Christophe Locher, Franck Bonnetain, Christelle De La Fouchardiere, Simon Pernot
Publikováno v:
Journal of Clinical Oncology. 33:4123-4123
4123 Background: Both Folfirinox and Nab-paclitaxel plus Gemcitabine showed a benefit in terms of survival in first-line treatment of metastatic pancreatic adenocarcinoma (MPA) when compared to gem...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8ec8213c8888ccafcd3c46c15a81697e
https://doi.org/10.1200/jco.2015.33.15_suppl.4123
https://doi.org/10.1200/jco.2015.33.15_suppl.4123